Mark Crowther: How Artificial Intelligence Is Entering The Field of Hematology
Mark Crowther, Distinguished University Professor and Chair, Department of Medicine at McMaster University, shared on LinkedIn:
”Fair Warning: This One Is for the Hematologists… Mostly.
If your day does not typically involve peripheral smears, coagulation assays, or bone marrow biopsies, this may feel a bit niche.
But stay with me.
A recent article in The Hematologist from the American Society of Hematology examines how artificial intelligence is entering the field of hematology — and while the examples are specialty-specific, the implications are much broader.
AI is already influencing how we:
- Interpret laboratory data and digital morphology
- Analyze large-scale genomic and clinical datasets
- Synthesize literature and draft documentation
- Predict outcomes and support risk stratification
Hematology is a useful case study.
It is data-rich, image-heavy, and highly quantitative — an ideal testing ground for algorithmic tools.
But the core questions apply across medicine, engineering, education, and health systems:
- How do we validate these tools before adoption?
- How do we recognize and mitigate embedded bias?
- How do we train professionals to use AI critically rather than passively?
- Where does accountability sit when machines assist decision-making?
At institutions like McMaster University, these are not abstract issues.
They are central to our broader AI agenda — integrating innovation while preserving rigor, transparency, and professional judgment.
So yes — this post may disproportionately excite hematologists.
But the conversation is much larger than one specialty.
AI will not replace expertise. It will reshape how expertise is exercised.”
Title: Artificial Intelligence and Hematology: What’s Promising Today and What Will Impact Practice Tomorrow?
Authors: Vanessa Kennedy, Lori Muffly
Read the Full Article on The Hematologist
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 28, 2026, 17:03Investing in Education, Prevention, and Lifesaving Research for a Healthier Tomorrow – AHA
-
Feb 28, 2026, 17:00Pamela Gavin: 1 in 10 Americans Live With A Rare Disease – That Is Not Rare, That Is Public Health
-
Feb 28, 2026, 16:59Thomas Rocco Jr: Exploring Agentic AI in Cardiovascular Medicine
-
Feb 28, 2026, 16:50Rob Maloney: Normalcy Is Not A Small Thing In Rare Disease
-
Feb 28, 2026, 16:49Céline Chapelle: Evaluating 6-Month Risks of Recurrent VTE and Major Bleeding With Tinzaparin
-
Feb 28, 2026, 16:46Nicolas Hulscher: Nattokinase Dissolves 84% of Amyloid Microclots In Vitro
-
Feb 28, 2026, 16:46Alfonso Tafur: Preventing Post-Hospitalization Blood Clots Using Precision Tools and Systems
-
Feb 28, 2026, 16:39Anel Karisik: Do Antidepressants Influence Swallowing Recovery After Acute Ischemic Stroke?
-
Feb 28, 2026, 16:38Akinchan Bhardwaj: Targeting SBK2 for Selective Inflammasome Resolution in Atherosclerosis